4.5 Article

Co-infection with Mycobacterium tuberculosis and Nocardia farcinica in a COPD patient: a case report

期刊

BMC PULMONARY MEDICINE
卷 23, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12890-023-02434-3

关键词

Nocardia; Tuberculosis; Co-infection; COPD; Diagnosis

向作者/读者索取更多资源

A COPD patient presented with worsening respiratory symptoms and received initial treatment in a primary hospital. Microbiological examination was not conducted during the first visit, leading to ineffective empirical antibiotic treatment. After referral to another hospital, the patient was diagnosed with co-infection of Mycobacterium tuberculosis and Nocardia. Appropriate treatment resulted in gradual improvement and discharge.
BackgroundChronic obstructive pulmonary disease (COPD) is a common respiratory disease characterized by persistent airflow limitation. Infection with either Mycobacterium tuberculosis or Nocardia in COPD patients has been reported. However, co-infection with Mycobacterium tuberculosis and Nocardia is rare. Herein, we described such a patient with COPD in a primary hospital, and the diagnosis process.Case presentationA 79-year-old female farmer with COPD was consecutively admitted to two hospitals with chief complaints of worsening cough, sputum and gasping since January10, 2022. Microbiological examination was not performed at the first hospital due to unknown reasons, and empirical antibiotic treatment was not effective. The patient was subsequently referred to our hospital. After screening the source of infection and the pathogen, she was diagnosed with tuberculosis. However, the patient did not benefit from antituberculosis treatment, with no remission of respiratory tract symptoms. Cerebrospinal fluid and bronchoalveolar lavage fluid specimens were subsequently sent for microbiological examination. The results indicated Mycobacterium tuberculosis and Nocardia.spp. After four days of bacterial culture, Nocardia.spp grew on medium, and Nocardia.farcinica was identified by the MALDI-TOF MS system and 16 s RNA. The patient was prescribed trimethoprim sulfamethoxazole (TMP/SMX) in combination with anti-tuberculosis drugs to treat the co-infection. She showed gradual improvement and was discharged from the hospital on February 19, 2022. However, the follow-up results were unclear.ConclusionsCo-infection with Nocardia and Mycobacterium tuberculosis should be considered in COPD patients. Repeated microbiological and microscopy examinations are essential in primary hospitals.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据